Technology | June 22, 2012

New Jetstream Atherectomy Catheter Creates Larger Lumen


June 22, 2012 — Bayer HealthCare widens its portfolio of interventional solutions by introducing the Jetstream Navitus L atherectomy catheter. Positioned as the largest diameter rotational atherectomy device in the Jetstream catheter family, the Navitus L catheter can create a lumen 30 percent larger than the standard Navitus device. 

Intended to treat above-the-knee peripheral artery disease (PAD), the Navitus L can be used in multiple lesions morphologies, including calcium and thrombus while providing differential cutting, to remove the lesion materials while preserving the soft vessel walls.  Like all Jetstream atherectomy catheters, the Navitus L provides continuous, active aspiration and the unique front-facing cutting head. Like the original Navitus, the Navitus L offers two-stage cutting with expandable blade technology allowing physicians to treat both common femoral artery (CFA) and superficial femoral artery (SFA) disease with a single catheter. 

For more information: www.interventional.bayer.com

 


Related Content

News | Thrombectomy Devices

Jan. 15, 2026 — Boston Scientific Corp. and Penumbra, Inc. have entered into a definitive agreement under which Boston ...

Home January 19, 2026
Home
News | Thrombectomy Devices

Dec. 10, 2025 — Medtronic plc has announced the first commercial use of the Liberant thrombectomy system (Liberant) ...

Home January 07, 2026
Home
News | Thrombectomy Devices

Dec. 16, 2025 — A new study, published in the American Journal of Cardiology, found that the use of Computer Assisted ...

Home December 23, 2025
Home
News | Thrombectomy Devices

Nov. 3, 2025 — Penumbra, Inc. has announced additional results of the STORM-PE randomized controlled trial (RCT), which ...

Home November 07, 2025
Home
News | Thrombectomy Devices

Oct. 27, 2025 – Penumbra, Inc. has announced the results of the STORM-PE randomized controlled trial (RCT), which found ...

Home October 27, 2025
Home
News | Thrombectomy Devices

Sept. 2, 2025 — Imperative Care, Inc. has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its ...

Home September 02, 2025
Home
News | Thrombectomy Devices

June 16, 2025 – Penumbra, Inc. recently announced the completion of enrollment in the STORM-PE clinical trial. This ...

Home June 16, 2025
Home
News | Thrombectomy Devices

March 24, 2025 — Imperative Care, Inc. recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance of ...

Home March 24, 2025
Home
News | Thrombectomy Devices

Penumbra recently launched its Element Vascular Access System, a laser-cut hypotube sheath designed for venous ...

Home January 30, 2025
Home
News | Thrombectomy Devices

Nov. 5, 2024 —Penumbra, Inc. recently announced new data that demonstrate patients with intermediate-risk pulmonary ...

Home November 07, 2024
Home
Subscribe Now